What is Circle Cardiovascular Imaging?
Established in 2007 and headquartered in Calgary, Alberta, Circle Cardiovascular Imaging provides a comprehensive suite of services dedicated to cardiac imaging. The company operates at the intersection of healthcare and advanced software engineering, delivering high-fidelity diagnostic tools that assist clinicians in interpreting complex cardiovascular data. By focusing on precision and diagnostic accuracy, Circle Cardiovascular Imaging has carved out a significant market share, positioning itself as an essential partner for healthcare providers seeking to optimize patient outcomes through data-driven insights.
How much funding has Circle Cardiovascular Imaging raised?
Circle Cardiovascular Imaging has raised a total of $19.9M across 2 funding rounds:
Private Equity
$3.9M
Series A
$16M
Private Equity (2011): $3.9M with participation from Business Development Bank of Canada and Foundation Equity II Limited Partnership
Series A (2018): $16M led by Kayne Anderson Capital Advisors and Yaletown Partners
Key Investors in Circle Cardiovascular Imaging
Kayne Anderson Capital Advisors
Kayne Anderson Capital Advisors, L.P. is an alternative investment management firm with a focus on energy, infrastructure, real estate, credit, and growth equity.
Yaletown Partners
Yaletown Partners focuses on transforming industries through technology investments that foster sustainable and impactful change, specializing in driving growth for innovative companies.
Business Development Bank of Canada
BDC Business Development Bank of Canada provides a wide range of financial and consulting services to small businesses, concentrating on technology and exporting.
What's next for Circle Cardiovascular Imaging?
With a history of major enterprise-level funding, Circle Cardiovascular Imaging is well-positioned to accelerate its product development roadmap and expand its global footprint. The strategic deployment of capital will likely focus on enhancing the integration of artificial intelligence within its imaging software, thereby reducing diagnostic latency and improving clinical workflows. As the company matures, the focus will shift toward scaling its commercial operations and deepening its penetration into international markets, where the demand for advanced cardiovascular diagnostic solutions continues to rise. The firm remains a key candidate for further strategic partnerships or potential consolidation within the broader health-tech ecosystem.
See full Circle Cardiovascular Imaging company page
